United States · FDA National Drug Code directory
HyperRAB
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13533-318_880a0273-4487-4f86-a949-2c91898bdd78
- Product NDC
- 13533-318
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Rabies Immune Globulin (Human)
- Labeler
- GRIFOLS USA, LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 19740612
- Source listing expiry
- 20261231
Source-listed ingredients
- HUMAN RABIES VIRUS IMMUNE GLOBULIN — 300 [iU]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (13533-318-01) / 1 mL in 1 VIAL (13533-318-10) · 13533-318-01
- 1 VIAL in 1 CARTON (13533-318-03) / 3 mL in 1 VIAL (13533-318-30) · 13533-318-03
- 1 VIAL in 1 CARTON (13533-318-05) / 5 mL in 1 VIAL (13533-318-50) · 13533-318-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →